Thus, these results suggest that the proposed activation of p38MAPK-MAPKAPK2-Hsp27 pathway through the decrease in PP2A expression may be common in the in vitro enriched TICs of many different cancer cell types. The gene discussed is MAPKAPK2; the disease is cancer.